400 India Drug Makers Said To Have Complied With Essential Drug Pricing
This article was originally published in PharmAsia News
Four hundred drug makers in the India market reportedly have complied with a health ministry request to identify medicines considered essential to the nation's drug-pricing policy.
You may also be interested in...
Drawing on the company’s Latin name, Viatris – the proposed combination of Mylan and Upjohn – has unveiled a logo and branding “capturing the company’s commitment to access, leadership and partnership.”
Having recently signed a gene therapy collaboration with Sarepta and received a positive opinion from the CHMP for its kidney transplant therapy, Sweden's Hansa has now raised a substantial sum in a "multiple times oversubscribed" placing.
The UK government has awarded “urgent public health status” to a clinical trial program that will test one investigational product and four existing drugs in an effort to quickly find new treatments for patients hospitalized with serious COVID-19 infection.